Corcept Therapeutics' earnings and sales beat not only demonstrates the company's strong performance but also surpasses analyst expectations, which is likely to positively influence investor sentiment and potentially lead to a short-term increase in stock price. The significant year-over-year sales growth further underscores the company's growth trajectory, enhancing its attractiveness to investors.